Tuesday, December 15, 2015

New "Big Data" Brings Total Number of Breast Cancer Patients Studied to 50,000, Demonstrating Oncotype DX® Accurately Predicts Clinical Outcomes

… DX® breast cancer test studies at the 38th CTRC-AACR San Antonio Breast Cancer Symposium … recurrence and breast cancer survival – in early-stage patients with invasive breast cancer. Data include … with node-negative breast cancer – a subgroup that showed significantly worse breast cancer survival and …

No comments:

Post a Comment